Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
MOMA Therapeutics
MOMA Therapeutics
Kivu Bioscience Inc.
AbbVie
Travera Inc
Eli Lilly and Company
Nammi Therapeutics Inc
Beijing Biotech
Jazz Pharmaceuticals
Bayer
Actuate Therapeutics Inc.
Eli Lilly and Company
Filamon LTD
AstraZeneca
NeoImmuneTech
Hoffmann-La Roche
Psyence Australia Pty Ltd
ViroMissile, Inc.
AstraZeneca
MBrace Therapeutics
A2 Biotherapeutics Inc.
Angiex, Inc.
Poseida Therapeutics, Inc.
MacroGenics
General Oncology, Inc.
Daiichi Sankyo
SN BioScience
Takeda
EXoPERT
Adela, Inc
Natera, Inc.
Second Life Therapeutics
Eli Lilly and Company
Var2 Pharmaceuticals
Incyte Corporation
Merck Sharp & Dohme LLC
VelosBio Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Nuvation Bio Inc.
Tempus AI
Massive Bio, Inc.
Incyte Corporation
Actym Therapeutics, Inc.
AVM Biotechnology Inc
LigaChem Biosciences, Inc.
Exelixis
Memgen, Inc.
TCR2 Therapeutics
Palleon Pharmaceuticals, Inc.
Sensei Biotherapeutics, Inc.
AstraZeneca
Senhwa Biosciences, Inc.